Clinical Trials Browser

Advanced Breast Cancer × disitamab vedotin × 90 days × Clear all

NCT05831878 2026-05-13

RC48-ADC in HER2-low Advanced Breast Cancer

Phase NA Recruiting

Advanced Breast Cancer